Try
PTC Therapeutics Inc. Common Stock
PTCTUnited States
52 filed reports · 528 financial concepts · 1 earnings calls · 0 media appearances
Filed reports
52 reports · Dec 2016 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 26 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 29 | 5,553 | Mar 2017 to Jun 2026 |
| Current · 8-KSEC EDGAR | 12 | 24 | Mar 2017 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 10 | 4,901 | Dec 2016 to Dec 2025 |
| Annual · 10-K/ASEC EDGAR | 1 | 1 | Dec 2022 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Jul 30, 2026 | 425 | Open |
| FY2026 Q2 | 8-K | Jun 30, 2026 | Jul 30, 2026 | 2 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 7, 2026 | 288 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Feb 19, 2026 | 1,087 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Nov 4, 2025 | 344 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Aug 7, 2025 | 218 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 6, 2025 | 200 | Open |
| FY2024 | 10-K | Dec 31, 2024 | Feb 27, 2025 | 482 | Open |
| FY2024 Q3 | 10-Q | Sep 30, 2024 | Nov 7, 2024 | 191 | Open |
| FY2024 Q2 | 10-Q | Jun 30, 2024 | Aug 8, 2024 | 187 | Open |
| FY2024 Q1 | 10-Q | Mar 31, 2024 | Apr 25, 2024 | 184 | Open |
| FY2023 | 10-K | Dec 31, 2023 | Feb 29, 2024 | 457 | Open |
Financial data
528 concepts · 10,479 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial505 concepts · 9,742 facts · Dec 2014 to Jul 2026
- Net income loss58 · Dec 2014 to Jun 2026
- Operating expenses (US GAAP)58 · Dec 2014 to Jun 2026
- Operating income loss58 · Dec 2014 to Jun 2026
- Cash and cash equivalents at carrying value56 · Dec 2014 to Jun 2026
- Accretion amortization of discounts and premiums investments54 · Dec 2014 to Jun 2026
- Allocated share based compensation expense54 · Dec 2014 to Jun 2026
- Amortization of financing costs54 · Dec 2014 to Jun 2026
- Comprehensive income net of tax54 · Dec 2014 to Jun 2026
- Foreign currency transaction gain loss unrealized54 · Dec 2014 to Jun 2026
- Income tax expense benefit54 · Dec 2014 to Jun 2026
- Increase decrease in accounts payable and accrued liabilities54 · Dec 2014 to Jun 2026
- Increase decrease in deposit other assets54 · Dec 2014 to Jun 2026
- Increase decrease in prepaid deferred expense and other assets54 · Dec 2014 to Jun 2026
- Increase decrease in receivables54 · Dec 2014 to Jun 2026
- Interest income expense nonoperating net54 · Dec 2014 to Jun 2026
- Other comprehensive income availableforsale securities adjustment net of tax portion attributable to parent54 · Dec 2014 to Jun 2026
- Other comprehensive income foreign currency transaction and translation adjustment net of tax portion attributable to parent54 · Dec 2014 to Jun 2026
- Other nonoperating income expense54 · Dec 2014 to Jun 2026
- Payments to acquire property plant and equipment54 · Dec 2014 to Jun 2026
- Proceeds from stock options exercised54 · Dec 2014 to Jun 2026
- Research and development expense54 · Dec 2014 to Jun 2026
- Revenue54 · Dec 2014 to Jun 2026
- Share based compensation54 · Dec 2014 to Jun 2026
- Increase decrease in inventories53 · Dec 2015 to Jun 2026
Product5 concepts · 411 facts · Dec 2015 to Jun 2026
- Revenue391 · Dec 2016 to Jun 2026
- Contract with customer liability revenue recognized9 · Jun 2023 to Dec 2024
- Number of countries5 · Dec 2017 to Sep 2019
- Sales revenue goods gross4 · Dec 2015 to Dec 2017
- Net product revenue2 · Mar 2018
Geography6 concepts · 153 facts · Dec 2014 to Jun 2026
- Revenue68 · Dec 2015 to Jun 2026
- Net product revenue32 · Dec 2017 to Jun 2021
- Property, Plant & Equipment, Net22 · Dec 2015 to Dec 2025
- Total Assets22 · Dec 2015 to Dec 2025
- Income loss from continuing operations before income taxes extraordinary items noncontrolling interest6 · Dec 2014 to Dec 2016
- Income tax expense benefit3 · Dec 2014 to Dec 2016
Segment11 concepts · 149 facts · Dec 2022 to Jun 2026
- Labor and related expense14 · Dec 2022 to Jun 2026
- Manufacturing costs14 · Dec 2022 to Jun 2026
- Net income loss14 · Dec 2022 to Jun 2026
- Operating segments14 · Dec 2022 to Jun 2026
- Revenue14 · Dec 2022 to Jun 2026
- Segment reporting other item amount14 · Dec 2022 to Jun 2026
- Amortization of intangible assets13 · Dec 2023 to Jun 2026
- Depreciation13 · Dec 2023 to Jun 2026
- Income tax expense benefit13 · Dec 2023 to Jun 2026
- Interest expense nonoperating13 · Dec 2023 to Jun 2026
- Investment income interest13 · Dec 2023 to Jun 2026
Guidance1 concepts · 24 facts · May 2017 to Jul 2026
- Revenue Guidance24 · May 2017 to Jul 2026
Segments
713 factsFigures broken down by business line, region, product or another axis the company reports on.
Product or servicesrt:ProductOrServiceAxis17 members · 397 facts
- Product93 · Dec 2016 to Jun 2026
- Translarna45 · Dec 2016 to Jun 2026
- Emflaza44 · Dec 2017 to Jun 2026
- Royalty33 · Sep 2019 to Jun 2026
- Grant And Collaboration32 · Dec 2016 to Jun 2023
- Manufacturing30 · Dec 2021 to Dec 2025
- Other Products24 · Dec 2023 to Jun 2026
- Upstaza And Kebilidi17 · Dec 2023 to Jun 2026
- Licensing And Collaboration Agreement15 · Dec 2016 to Sep 2020
- Sephience15 · Sep 2025 to Jun 2026
- Collaboration Revenue10 · Dec 2021 to Dec 2024
- Collaboration And License Revenue8 · Dec 2023 to Jun 2026
- Discovery Agreements8 · Sep 2017 to Mar 2020
- Early Stage Collaborations8 · Sep 2017 to Mar 2020
- Upstaza7 · Jun 2024 to Sep 2025
- Translarna16 · Dec 2023 to Dec 2025
- Grant2 · Dec 2016 to Dec 2018
Statement business segments1 member · 149 facts
- Life Science149 · Dec 2022 to Jun 2026
Statement geographicalsrt:StatementGeographicalAxis5 members · 94 facts
- US34 · Dec 2017 to Jun 2026
- Non Us25 · Dec 2017 to Dec 2025
- All Other Countries Other Than Russia Brazil And United States12 · Dec 2023 to Jun 2026
- BR12 · Dec 2023 to Jun 2026
- RU11 · Dec 2023 to Jun 2026
Statement geographicalus-gaap:StatementGeographicalAxis5 members · 59 facts
- Us22 · Dec 2015 to Dec 2025
- Non us22 · Dec 2015 to Dec 2025
- Non Us6 · Dec 2014 to Dec 2017
- US6 · Dec 2014 to Dec 2017
- NJ3 · Dec 2014 to Dec 2016
Product or serviceus-gaap:ProductOrServiceAxis5 members · 14 facts
- Translarna6 · Dec 2015 to Mar 2018
- Discovery Agreements2 · Mar 2017 to Mar 2018
- Early Stage Collaborations2 · Mar 2017 to Mar 2018
- Emflaza2 · Dec 2017 to Mar 2018
- Licensing And Collaboration Agreement2 · Mar 2017 to Mar 2018
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Earnings-release commentary58 claims from 7 reports · Dec 2024 to Jun 2026
- Management discussion (MD&A) commentary167 claims from 8 reports · Sep 2024 to Jun 2026
- Risk-factor changes22 claims from 1 reports · Dec 2025
- Risk factors98 risks from 2 annual reports · 2024 to 2025
Earnings calls
1 calls · Jul 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Jul 30, 2026
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 17, 2026) and refreshed every few hours.